Memphasys Ltd (AU:MEM) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Memphasys Limited has appointed Lindley Edwards as the new Non-Executive Chairperson, succeeding Robert Cooke, as the company nears the completion of its clinical trial for the Felix™ System. Edwards brings over 30 years of experience in financial services and corporate governance, aiming to steer Memphasys towards global commercialisation of its sperm separation technology and RoXsta™ System. These advancements are set to strengthen Memphasys’ position in the fertility and biotechnology markets.
For further insights into AU:MEM stock, check out TipRanks’ Stock Analysis page.
